307 related articles for article (PubMed ID: 17513793)
1. Abrogation of lupus nephritis in activation-induced deaminase-deficient MRL/lpr mice.
Jiang C; Foley J; Clayton N; Kissling G; Jokinen M; Herbert R; Diaz M
J Immunol; 2007 Jun; 178(11):7422-31. PubMed ID: 17513793
[TBL] [Abstract][Full Text] [Related]
2. Activation-induced deaminase-deficient MRL/lpr mice secrete high levels of protective antibodies against lupus nephritis.
Jiang C; Zhao ML; Scearce RM; Diaz M
Arthritis Rheum; 2011 Apr; 63(4):1086-96. PubMed ID: 21225690
[TBL] [Abstract][Full Text] [Related]
3. The Role of IgM Antibodies in T Cell Lymphoma Protection in a Novel Model Resembling Anaplastic Large Cell Lymphoma.
Jiang C; Zhao ML; Ramos L; Dobaczewska K; Herbert R; Hobbie K; Mikulski Z; Verkoczy L; Diaz M
J Immunol; 2021 May; 206(10):2468-2477. PubMed ID: 33883189
[TBL] [Abstract][Full Text] [Related]
4. The role of activation-induced deaminase in lupus nephritis.
Diaz M
Autoimmunity; 2013 Mar; 46(2):115-20. PubMed ID: 23215788
[TBL] [Abstract][Full Text] [Related]
5. Activation-induced deaminase heterozygous MRL/lpr mice are delayed in the production of high-affinity pathogenic antibodies and in the development of lupus nephritis.
Jiang C; Zhao ML; Diaz M
Immunology; 2009 Jan; 126(1):102-13. PubMed ID: 18624728
[TBL] [Abstract][Full Text] [Related]
6. Deficiency in activation-induced cytidine deaminase promotes systemic autoimmunity in lpr mice on a C57BL/6 background.
Chen L; Guo L; Tian J; Zheng B; Han S
Clin Exp Immunol; 2010 Feb; 159(2):169-75. PubMed ID: 19922498
[TBL] [Abstract][Full Text] [Related]
7. Autoantibody responses and pathology regulated by B7-1 and B7-2 costimulation in MRL/lpr lupus.
Liang B; Kashgarian MJ; Sharpe AH; Mamula MJ
J Immunol; 2000 Sep; 165(6):3436-43. PubMed ID: 10975864
[TBL] [Abstract][Full Text] [Related]
8. Expression of natural autoantibodies in MRL-lpr mice protects from lupus nephritis and improves survival.
Mannoor K; Matejuk A; Xu Y; Beardall M; Chen C
J Immunol; 2012 Apr; 188(8):3628-38. PubMed ID: 22407922
[TBL] [Abstract][Full Text] [Related]
9. AID dysregulation in lupus-prone MRL/Fas(lpr/lpr) mice increases class switch DNA recombination and promotes interchromosomal c-Myc/IgH loci translocations: modulation by HoxC4.
White CA; Seth Hawkins J; Pone EJ; Yu ES; Al-Qahtani A; Mai T; Zan H; Casali P
Autoimmunity; 2011 Dec; 44(8):585-98. PubMed ID: 21585311
[TBL] [Abstract][Full Text] [Related]
10. Negative role of colony-stimulating factor-1 in macrophage, T cell, and B cell mediated autoimmune disease in MRL-Fas(lpr) mice.
Lenda DM; Stanley ER; Kelley VR
J Immunol; 2004 Oct; 173(7):4744-54. PubMed ID: 15383612
[TBL] [Abstract][Full Text] [Related]
11. Fas and Fas ligand mutations inhibit autoantibody production in pristane-induced lupus.
Satoh M; Weintraub JP; Yoshida H; Shaheen VM; Richards HB; Shaw M; Reeves WH
J Immunol; 2000 Jul; 165(2):1036-43. PubMed ID: 10878381
[TBL] [Abstract][Full Text] [Related]
12. Costimulation by B7-1 and B7-2 is required for autoimmune disease in MRL-Faslpr mice.
Kinoshita K; Tesch G; Schwarting A; Maron R; Sharpe AH; Kelley VR
J Immunol; 2000 Jun; 164(11):6046-56. PubMed ID: 10820290
[TBL] [Abstract][Full Text] [Related]
13. IL-12 deficiency in MRL-Fas(lpr) mice delays nephritis and intrarenal IFN-gamma expression, and diminishes systemic pathology.
Kikawada E; Lenda DM; Kelley VR
J Immunol; 2003 Apr; 170(7):3915-25. PubMed ID: 12646661
[TBL] [Abstract][Full Text] [Related]
14. Lupus-prone MRL/faslpr/lpr mice display increased AID expression and extensive DNA lesions, comprising deletions and insertions, in the immunoglobulin locus: concurrent upregulation of somatic hypermutation and class switch DNA recombination.
Zan H; Zhang J; Ardeshna S; Xu Z; Park SR; Casali P
Autoimmunity; 2009 Feb; 42(2):89-103. PubMed ID: 19156553
[TBL] [Abstract][Full Text] [Related]
15. Intrathymic kidney cells delay the onset of lupus nephritis in MRL-lpr/lpr mice.
Bloom RD; O'Connor T; Cizman B; Kalluri R; Naji A; Madaio MP
Int Immunol; 2002 Aug; 14(8):867-71. PubMed ID: 12147623
[TBL] [Abstract][Full Text] [Related]
16. Role of the costimulatory molecule CD28 in the development of lupus in MRL/lpr mice.
Tada Y; Nagasawa K; Ho A; Morito F; Koarada S; Ushiyama O; Suzuki N; Ohta A; Mak TW
J Immunol; 1999 Sep; 163(6):3153-9. PubMed ID: 10477582
[TBL] [Abstract][Full Text] [Related]
17. Effects of complement factor D deficiency on the renal disease of MRL/lpr mice.
Elliott MK; Jarmi T; Ruiz P; Xu Y; Holers VM; Gilkeson GS
Kidney Int; 2004 Jan; 65(1):129-38. PubMed ID: 14675043
[TBL] [Abstract][Full Text] [Related]
18. Deletion of receptor for advanced glycation end products exacerbates lymphoproliferative syndrome and lupus nephritis in B6-MRL Fas lpr/j mice.
Goury A; Meghraoui-Kheddar A; Belmokhtar K; Vuiblet V; Ortillon J; Jaisson S; Devy J; Le Naour R; Tabary T; Cohen JH; Schmidt AM; Rieu P; Touré F
J Immunol; 2015 Apr; 194(8):3612-22. PubMed ID: 25762779
[TBL] [Abstract][Full Text] [Related]
19. B cells are required for lupus nephritis in the polygenic, Fas-intact MRL model of systemic autoimmunity.
Chan OT; Madaio MP; Shlomchik MJ
J Immunol; 1999 Oct; 163(7):3592-6. PubMed ID: 10490951
[TBL] [Abstract][Full Text] [Related]
20. Lupus nephritis in the absence of renal major histocompatibility complex class I and class II molecules.
Mukherjee R; Zhang Z; Zhong R; Yin ZQ; Roopenian DC; Jevnikar AM
J Am Soc Nephrol; 1996 Nov; 7(11):2445-52. PubMed ID: 8959638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
